Optimizing triple negative breast cancer therapy based on immune cell morphology
Optimizing triple negative breast cancer therapy based on immune cell morphology
批准号:
468140
负责人:
Nielsen Torsten O
金额:
$4.37万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-02-01 至 2024-02-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Women diagnosed with triple negative breast cancer face an aggressive, life-threatening disease. Intense chemotherapy remains part of their standard care. However, new evidence suggests that at least some of these breast cancers are cured by surgery and r
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translating Epigenomics into Clinical Care for Synovial Sarcoma
-
批准号:479075
-
项目类别:Operating Grants
-
资助金额:$69.11万
-
财政年份:2023
-
负责人:Nielsen Torsten O
-
依托单位:
Translating Epigenomics into Clinical Care for Synovial Sarcoma
-
批准号:473362
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2022
-
负责人:Nielsen Torsten O
-
依托单位:
CSF1 pathway inhibitors in tenosynovial giant cell tumors and leiomyosarcoma
-
批准号:200438
-
项目类别:Operating Grants
-
资助金额:$21.12万
-
财政年份:2010
-
负责人:Nielsen Torsten O
-
依托单位:
海外基金